ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
ShockWave Medical, Inc. (SWAV) stock declined over -0.02%, trading at $334.75 on NASDAQ, down from the previous close of $334.83. The stock opened at $334.85, fluctuating between $334.75 and $334.90 in the recent session.
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Employees | 1468 |
Beta | 0.88 |
Sales or Revenue | $730.23M |
5Y Sales Change% | 42.65% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep